Details for 2019844990

Up to date per 01.04.2026

Actions

Title / Product Name

KOMBINATIONSPRODUKT AUS BCL-2-INHIBITOR UND MDM2-INHIBITOR UND VERWENDUNG DAVON ZUR PRÄVENTION UND/ODER BEHANDLUNG VON KRANKHEITEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2019844990

EP Publication Number

3672594

E-Number

1433604

Language

PCT Number

CN19096968

Publication Date

01.07.2020 A

29.09.2021 B1

Registration Date

29.09.2021

AT Publication Date

15.10.2021

Application Date

22.07.2019

Registration Number

Priorities

31.07.2018

201810862170

IPC

A61K 31/496 20060101AFI20201019BHEP

Maximum Duration of Protection

22.07.2039

Owner

Ascentage Pharma (Suzhou) Co., Ltd.Unit 701, Building B7, 218 Xinghu Street Suzhou Industrial Park Suzhou, Jiangsu 215000CN

Representative

No representatives present

Inventor

YANG, DajunUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

ZHAI, YifanUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

TANG, QiuqiongUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN

FANG, Douglas DongUnit 701, Building B7, 218 Xinghu Street, Suzhou Industrial Park Suzhou, Jiangsu 215000CN